NASDAQ:ITUS - ITUS Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$4.61
Today's Range$4.61 - $4.76
52-Week Range$1.83 - $6.43
Volume69,859 shs
Average Volume134,373 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ITUS Corporation develops, acquires, and licenses emerging technologies in the areas of biotechnology. The company develops Cchek, a platform for non-invasive blood tests for the early detection of various cancers, including breast, lung, colon, melanoma, ovarian, liver, thyroid, pancreatic, appendiceal, uterine, osteosarcoma, leiomyosarcoma, liposarcoma, vulvar, and prostate cancer. It also develops immuno-therapy drugs for the treatment of cancer. The company was formerly known as CopyTele, Inc. and changed its name to ITUS Corporation in September 2014. ITUS Corporation was founded in 1982 and is based in San Jose, California.

Receive ITUS News and Ratings via Email

Sign-up to receive the latest news and ratings for ITUS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Patent owners & lessors
Sub-IndustryN/A
SectorBusiness Services
Current SymbolNASDAQ:ITUS
CUSIPN/A
Phone408-708-9808

Debt

Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Price / Cash FlowN/A
Price / BookN/A

Profitability

Net IncomeN/A
Net MarginsN/A
Return on AssetsN/A

Miscellaneous

Employees7
OptionableNot Optionable

ITUS (NASDAQ:ITUS) Frequently Asked Questions

What is ITUS's stock symbol?

ITUS trades on the NASDAQ under the ticker symbol "ITUS."

How were ITUS's earnings last quarter?

ITUS Corp (NASDAQ:ITUS) announced its earnings results on Friday, March, 9th. The business services provider reported ($0.11) earnings per share for the quarter. View ITUS's Earnings History.

Has ITUS been receiving favorable news coverage?

Media stories about ITUS stock have trended very positive on Wednesday, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. ITUS earned a media sentiment score of 3.9 on InfoTrie's scale. They also gave news stories about the business services provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days.

Who are some of ITUS's key competitors?

Who are ITUS's key executives?

ITUS's management team includes the folowing people:
  • Dr. Amit Kumar Ph.D., Exec. Chairman, Pres & CEO (Age 54)
  • Mr. Michael J. Catelani, COO, CFO & Corp. Sec. (Age 51)
  • Mr. John Roop, Sr. VP of Engineering (Age 68)
  • Mr. Anthony Campisi, VP of Engineering

How do I buy shares of ITUS?

Shares of ITUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ITUS's official website?

The official website for ITUS is http://www.ituscorp.com.

How can I contact ITUS?

ITUS's mailing address is 3150 ALMADEN EXPRESSWAY SUITE 250, SAN JOSE CA, 95118. The business services provider can be reached via phone at 408-708-9808 or via email at [email protected]


MarketBeat Community Rating for ITUS (NASDAQ ITUS)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  74 (Vote Outperform)
Underperform Votes:  108 (Vote Underperform)
Total Votes:  182
MarketBeat's community ratings are surveys of what our community members think about ITUS and other stocks. Vote "Outperform" if you believe ITUS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ITUS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/16/2019 by MarketBeat.com Staff

Featured Article: What is Liquidity?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel